The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Guide to Anticoagulant Therapy: Heparin: A Statement for Healthcare Professionals From the American Heart Association
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Self-citationThe Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Self-citation(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328
Self-citationThe pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Self-citation(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Anderson, F. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400050081016 · Cited by 1,669
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Self-citationWeitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
(1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390704 · Cited by 1,432
A Prospective Study of Venous Thromboembolism after Major Trauma
Geerts, W. H., Code, K. I., Jay, R. M., Chen, E., & Szalai, J. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412153312401 · Cited by 1,428
Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G. G., Fromell, G. J., Goodman, S., Langer, A., Califf, R. M., Fox, K. A. A., Premmereur, J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370702 · Cited by 1,424
ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
Barritt, D. W., & Jordan, S. C. (1960) · The Lancet · doi:10.1016/s0140-6736(60)92299-6 · Cited by 1,354
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,321
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
Théroux, P., Ouimet, H., McCans, J., Latour, J.-G., Joly, P., Lévy, G., Pelletier, E., Juneau, M., Stasiak, J., deGuise, P., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191701 · Cited by 1,276
RICHARDSON, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90953-7 · Cited by 1,258
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Self-citationA Prospective Study of Venous Thromboembolism After Major Trauma
Hollingsworth-Fridlund, P., Geerts, W. H., Code, K. I., Jay, R. M., Chen, E., & Szalai, J. P. (1997) · Journal of Trauma Nursing · doi:10.1097/00043860-199710000-00006 · Cited by 1,131
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Self-citationKoopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111
Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G. G., Bernink, P. J. L. M., Salein, D., Bayes de Luna, A., Fox, K., Lablanche, J.-M., Radley, D., et al. (1999) · Circulation · doi:10.1161/01.cir.100.15.1593 · Cited by 1,052
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Self-citationPatrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationImpact of the patient population on the risk for heparin-induced thrombocytopenia
Warkentin, T. E., Sheppard, J.-A. I., Horsewood, P., Simpson, P. J., Moore, J. C., & Kelton, J. G. (2000) · Blood · doi:10.1182/blood.v96.5.1703 · Cited by 924
Hunt, D. U., Varigos, G., Dienstl, F., Lechleitner, P., DeBacker, G., Kornitzer, M., Cairns, J., Turpie, A. G. G., Fritz-Hansen, P., Skagen, K., et al. (1992) · The Lancet · Cited by 894
Hirsh, J., & Levine, M. (1992) · Blood · doi:10.1182/blood.v79.1.1.bloodjournal7911 · Cited by 894
Self-citationA 14-year study of heparin-induced thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00258-6 · Cited by 886
Geerts, W. H., Jay, R. M., Code, K. I., Chen, E., Szalai, J. P., Saibil, E. A., & Hamilton, P. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609053351003 · Cited by 808
Suppression by heparin of smooth muscle cell proliferation in injured arteries
CLOWES, A. W., & KARNOWSKY, M. J. (1977) · Nature · doi:10.1038/265625a0 · Cited by 790
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Simonneau, G., Sors, H., Charbonnier, B., Page, Y., Laaban, J.-P., Azarian, R., Laurent, M., Hirsch, J.-L., Ferrari, E., Bosson, J.-L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371002 · Cited by 782
The RISC Group (1990) · The Lancet · doi:10.1016/0140-6736(90)92336-g · Cited by 781
Hull, R. D., Raskob, G. E., Hirsh, J., Jay, R. M., Leclerc, J. R., Geerts, W. H., Rosenbloom, D., Sackett, D. L., Anderson, C., Harrison, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610303151801 · Cited by 722
Self-citationSimoons, M. L. (1996) · RePub (Erasmus University Rotterdam) · Cited by 706
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Prevention of Venous Thromboembolism in General Surgical Patients: Results of Meta-analysis
CLAGETT, G. P., & REISCH, J. S. (1988) · Annals of Surgery · doi:10.1097/00000658-198808000-00016 · Cited by 691
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
Nurmohamed, M. T., Buller, H. R., Dekker, E., Hommes, D. W., Rosendaal, F. R., Briet, E., Rosendaal, F. R., & Vandenbroucke, J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)93223-a · Cited by 668
Basu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661
Self-citationA Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
(1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351103 · Cited by 660
Choay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Gould, M. K., Dembitzer, A. D., Doyle, R. L., Hastie, T. J., & Garber, A. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00003 · Cited by 627
The International Study Group (1990) · The Lancet · doi:10.1016/0140-6736(90)91590-7 · Cited by 620
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B., Russell, R. O., Smith, E. E., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00351-4 · Cited by 592
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109661 · Cited by 591
The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi
Baumgartner, H. R. (1973) · Microvascular Research · doi:10.1016/0026-2862(73)90069-1 · Cited by 584
Heparin-induced Thrombocytopenia: Towards Consensus
Warkentin, T. E., Chong, B. H., & Greinacher, A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614206 · Cited by 542
Davies, M. J., Thomas, A. C., Knapman, P. A., & Hangartner, J. R. (1986) · Circulation · doi:10.1161/01.cir.73.3.418 · Cited by 532
Turpie, A. G. G., Levine, M., Hirsh, J., Carter, C. J., Jay, R. M., Powers, P. J., Andrew, M. E., Hull, R. D., & Gent, M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610093151503 · Cited by 530
Self-citationTHE THROMBOPLASTIC ACTION OF CEPHALIN
McLean, J. (1916) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1916.41.2.250 · Cited by 530
Klein, W., Buchwald, A., Hillis, S. E., Monrad, S., Sanz, G., Turpie, A. G. G., van der Meer, J., Olaisson, E., Undeland, S., & Ludwig, K. (1997) · Circulation · doi:10.1161/01.cir.96.1.61 · Cited by 526
Agnelli, G., Piovella, F., Buoncristiani, P., Severi, P., Pini, M., D'Angelo, A., Beltrametti, C., Damiani, M., Andrioli, G. C., Pugliese, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390204 · Cited by 523
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Self-citationGreinacher, A., Pötzsch, B., Amiral, J., Dummel, V., Eichner, A., & Mueller-Eckhardt, C. (1994) · PubMed · Cited by 492
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Antman, E. M. (1996) · Circulation · doi:10.1161/01.cir.94.5.911 · Cited by 485
Heparin-induced thrombocytopenia: laboratory studies
Kelton, J., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., & Murphy, W. (1988) · Blood · doi:10.1182/blood.v72.3.925.925 · Cited by 483
Oler, A. (1996) · JAMA · doi:10.1001/jama.276.10.811 · Cited by 483
Greinacher, A., Völpel, H., Janssens, U., Hach-Wunderle, V., Kemkes-Matthes, B., Eichler, P., Mueller-Velten, H. G., & Pötzsch, B. (1999) · Circulation · doi:10.1161/01.cir.99.1.73 · Cited by 482
Brandjes, D. P. M., Heijboer, H., Büller, H. R., de Rijk, M., Jagt, H., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272103 · Cited by 480
Warkentin, T., Hayward, C., Boshkov, L., Santos, A., Sheppard, J., Bode, A., & Kelton, J. (1994) · Blood · doi:10.1182/blood.v84.11.3691.bloodjournal84113691 · Cited by 478
Antman, E. M., Cohen, M., Radley, D., McCabe, C., Rush, J., Premmereur, J., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.15.1602 · Cited by 476
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Hull, R. D., Raskob, G. E., Pineo, G. F., Rosenbloom, D., Evans, W. E., Mallory, T. H., Anquist, K., Smith, F., Hughes, G. W., Green, D., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291902 · Cited by 440
Management of Heparin Therapy: Controlled Prospective Trial
Salzman, E. W., Deykin, D., Shapiro, R. M., & Rosenberg, R. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505152922002 · Cited by 435
Plaque fissures in human coronary thrombosis
Constantinides, P. (1966) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(66)80056-x · Cited by 426
Hsia, J., Hamilton, W. P., Kleiman, N., Roberts, R., Chaitman, B. R., & Ross, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011223232101 · Cited by 422
Berge, E., Abdelnoor, M., Nakstad, P., & Sandset, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02085-7 · Cited by 421
Roberts, W. C., & Buja, L. M. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90033-2 · Cited by 415
Levine, M. N. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.49 · Cited by 403
Cohen, M., Adams, P. C., Parry, G., Xiong, J., Chamberlain, D., Wieczorek, I., Fox, K. A., Chesebro, J. H., Strain, J., & Keller, C. (1994) · Circulation · doi:10.1161/01.cir.89.1.81 · Cited by 378
TRIPLET PREGNANCY AFTER PULSATILE ADMINISTRATION OF GONADOTROPIN RELEASING HORMONE
Bogchelman, D., Lappöhn, R. E., & Janssens, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91180-1 · Cited by 378
Structure of the antithrombin-binding site in heparin.
Lindahl, U., Bäckström, G., Höök, M., Thunberg, L., Fransson, L. A., & Linker, A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3198 · Cited by 368
Merli, G., Spiro, T. E., Olsson, C.-G., Abildgaard, U., Davidson, B. L., Eldor, A., Elias, D., Grigg, A., Musset, D., Rodgers, G. M., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00009 · Cited by 362
Hogg, P. J., & Jackson, C. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3619 · Cited by 347
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
Lane, D. A., Denton, J., Flynn, A. M., Thunberg, L., & Lindahl, U. (1984) · Biochemical Journal · doi:10.1042/bj2180725 · Cited by 342
Extension and structural variability of the antithrombin-binding sequence in heparin.
Lindahl, U., Thunberg, L., Bäckström, G., Riesenfeld, J., Nordling, K., & Björk, I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90755-6 · Cited by 340
Wallentin, L. C., Swahn, E., Kontny, F. P., Husted, S., Lagerqvist, B., Ståhle, E., Jd, N., Dellborg, M., Geiran, O. R., Grande, P., et al. (1999) · PubMed · Cited by 338
Jordan, R. E., Oosta, G. M., Gardner, W. T., & Rosenberg, R. D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70431-1 · Cited by 333
Carter, C., Kelton, J., Hirsh, J., Cerskus, A., Santos, A., & Gent, M. (1982) · Blood · doi:10.1182/blood.v59.6.1239.1239 · Cited by 331
Self-citationHeras, M., Chesebro, J. H., Penny, W. J., Bailey, K. R., Badimon, L., & Fuster, V (1989) · Circulation · doi:10.1161/01.cir.79.3.657 · Cited by 331
Self-citationEstablishing a Therapeutic Range for Heparin Therapy
Brill-Edwards, P., Ginsberg, J. S., Johnston, M., & Hirsh, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00002 · Cited by 329
Self-citationGurfinkel, E. P., Manos, E. J., Mejaíl, R. I., Cerdá, M. A., Duronto, E. A., García, C. N., Daroca, A. M., & Mautner, B. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80001-w · Cited by 326
Casu, B., Oreste, P., Torri, G., Zoppetti, G., Choay, J., Lormeau, J. C., Petitou, M., & Sinaɕ, P. (1981) · Biochemical Journal · doi:10.1042/bj1970599 · Cited by 326
Manning, W. J., Silverman, D. I., Keighley, C. S., Oettgen, P., & Douglas, P. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00560-d · Cited by 324
Turpie, A. G. G., Robinson, J. G., Doyle, D. J., Mulji, A. S., Mishkel, G. J., Sealey, B. J., Cairns, J. A., Skingley, L., Hirsh, J., & Gent, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200604 · Cited by 323
Self-citation(1999) · The Lancet · doi:10.1016/s0140-6736(98)07332-2 · Cited by 322
Castellot, J. J., Favreau, L. V., Karnovsky, M. J., & Rosenberg, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33750-5 · Cited by 310
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Leclerc, J., Powers, P. J., Jay, R. M., & Neemeh, J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-545 · Cited by 308
Self-citationGallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
Collins, R., Peto, R., Baigent, C., & Sleight, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703203361207 · Cited by 297
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.
Théroux, P., Waters, D., Qiu, S., McCans, J., de Guise, P., & Juneau, M. (1993) · Circulation · doi:10.1161/01.cir.88.5.2045 · Cited by 296
de Bono, D. P., Simoons, M. L., Tijssen, J., Arnold, A. E., Betriu, A., Burgersdijk, C., Lopez Bescos, L., Mueller, E., Pfisterer, M., & Van de Werf, F. (1992) · Heart · doi:10.1136/hrt.67.2.122 · Cited by 295
Correlation between structure and function of heparin
Rosenberg, R. D., & Lam, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1218 · Cited by 281
Leyvraz, P. F., Richard, J., Bachmann, F., van Melle, G., Treyvaud, J.-M., Livio, J.-J., & Candardjis, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310203091605 · Cited by 281
Heparin kinetics in venous thrombosis and pulmonary embolism.
Hirsh, J., van Aken, W. G., Gallus, A. S., Dollery, C. T., Cade, J. F., & Yung, W. L. (1976) · Circulation · doi:10.1161/01.cir.53.4.691 · Cited by 277
Self-citationHighly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis
Abildgaard, U. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076981 · Cited by 275
Topol, E. J., George, B. S., Kereiakes, D. J., Stump, D. C., Candela, R. J., Abbottsmith, C. W., Aronson, L., Pickel, A., Boswick, J. M., & Lee, K. L. (1989) · Circulation · doi:10.1161/01.cir.79.2.281 · Cited by 275
A standard heparin nomogram for the management of heparin therapy
Cruickshank, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.2.333 · Cited by 266
Landefeld, C. S., Cook, E. F., Flatley, M., Weisberg, M., & Goldman, L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90004-0 · Cited by 264
Bleich, S. D., Nichols, T. C., Schumacher, R. R., Cooke, D. H., Tate, D. A., & Teichman, S. L. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90525-6 · Cited by 264
Francis, C. W. (1983) · JAMA · doi:10.1001/jama.1983.03330270038029 · Cited by 256
Kinetics of intravenously administered heparin in normal humans
de Swart, C., Nijmeyer, B., Roelofs, J., & Sixma, J. (1982) · Blood · doi:10.1182/blood.v60.6.1251.1251 · Cited by 253
Danielsson, A., Raub, E., Lindahl, U., & Björk, I. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66735-3 · Cited by 252
Plasma P-selectin is increased in thrombotic consumptive platelet disorders
Chong, B., Murray, B., Berndt, M., Dunlop, L., Brighton, T., & Chesterman, C. (1994) · Blood · doi:10.1182/blood.v83.6.1535.1535 · Cited by 250
HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPY
Mant, M., Thong, K. L., Birtwhistle, R., O'Brien, B., Hammond, G., & Grace, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92388-1 · Cited by 242
Holmer, E., Kurachi, K., & Söderström, G. (1981) · Biochemical Journal · doi:10.1042/bj1930395 · Cited by 239
A Standard Heparin Nomogram for the Management of Heparin Therapy
Cruickshank, M. K. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400020085018 · Cited by 237
Brinkhous, K. M., Smith, H. P., Warner, E. D., & Seegers, W. H. (1939) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1939.125.4.683 · Cited by 234
Leclerc, J. R., Geerts, W. H., Desjardins, L., Laflamme, G. H., l'Esperance, B., Demers, C., Kassis, J., Cruickshank, M., Whitman, L., & Delorme, F. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00001 · Cited by 233
Binding of heparin on the surface of cultured human endothelial cells
Glimelius, B., Busch, C., & Höök, M. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90271-2 · Cited by 233
The Mode of Action of Heparin in Plasma
Béguin, S., Lindhout, T., & Hemker, H. C. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646990 · Cited by 230
Hemorrhagic Transformation in Acute Ischemic Stroke: The MAST-E Study
Jaillard, A., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., & Hommel, M. (1999) · Stroke · doi:10.1161/01.str.30.7.1326 · Cited by 225
STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
Choay, J., Lormeau, J., Petitou, M., Sinay, P., & Fareed, J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb29770.x · Cited by 224
RANDOMISED CONTROLLED TRIAL OF SUBCUTANEOUS CALCIUM-HEPARIN IN ACUTE MYOCARDIAL INFARCTION
(1989) · The Lancet · doi:10.1016/s0140-6736(89)90371-1 · Cited by 223
Badimon, L., & Badimon, J. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114277 · Cited by 220
Leclerc, J. R., Geerts, W. H., Desjardins, L., Jobin, F., Laroche, F., Delorme, F., Haviernick, S., Atkinson, S., & Bourgouine, J. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648463 · Cited by 220
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214
Randomized Prospective Trial of Continuous vs Intermittent Heparin Therapy
Glazier, R. L. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270130027021 · Cited by 205
Bar-Shavit, R., Eldor, A., & Vlodavsky, I. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114272 · Cited by 205
Turpie, A. G., Hirsh, J., Jay, R., Andrew, M., Hull, R., Levine, M., Carter, C., Powers, P., Magnani, H., & Gent, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90173-5 · Cited by 200
Self-citationHeparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
Sobel, M., McNeill, P. M., Carlson, P. L., Kermode, J. C., Adelman, B., Conroy, R., & Marques, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115198 · Cited by 197
Collins, R., MacMahon, S., Flather, M., Baigent, C., Remvig, L., Mortensen, S., Appleby, P., Godwin, J., Yusuf, S., & Peto, R. (1996) · BMJ · doi:10.1136/bmj.313.7058.652 · Cited by 196
Binding and endocytosis of heparin by human endothelial cells in culture
Bârzu, T., Molho, P., Tobelem, G., Petitou, M., & Caen, J. (1985) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(85)90177-6 · Cited by 192
Patrono, C., Coller, B., Dalen, J. E., Fuster, V., Gent, M., Harker, L. A., Hirsh, J., & Roth, G. (1998) · Chest · doi:10.1378/chest.114.5_supplement.470s · Cited by 190
Self-citation(1975) · PubMed · Cited by 189
Reduction of Mortality in General Medical In-patients by Low-Dose Heparin Prophylaxis
HALKIN, H., GOLDBERG, J., MODAN, M., & MODAN, B. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-561 · Cited by 187
Multiple functional domains of the heparin molecule.
Oosta, G. M., Gardner, W. T., Beeler, D. L., & Rosenberg, R. D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.829 · Cited by 187
ZHOU, L., KEANE, D., REED, G., & RUSKIN, J. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00719.x · Cited by 185
Chiu, H., Hirsh, J., Yung, W., Regoeczi, E., & Gent, M. (1977) · Blood · doi:10.1182/blood.v49.2.171.171 · Cited by 183
Self-citationDeterminants of donor platelet variability when testing for heparin-induced thrombocytopenia.
Warkentin, T. E., Hayward, C. P. M., Smith, C., Kelly, P. M., & Kelton, J. G. (1992) · PubMed · Cited by 182
Handeland, G. F., Abildgaard, U., Holm, H. A., & Arnesen, K. E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280041 · Cited by 181
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Söderström, G. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90159-2 · Cited by 172
DOYLE, D. J., TURPIE, A. G. G., HIRSH, J., BEST, C., KINCH, D., LEVINE, M. N., & GENT, M. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-441 · Cited by 171
Self-citationNeri Serneri, G. G., Gensini, G. F., Poggesi, L., Trotta, F., Modesti, P. A., Boddi, M., Ieri, A., Margheri, M., Casolo, G. C., Bini, M., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90407-v · Cited by 170
Frydman, A. M., Bara, L., Roux, Y. H., Woler, M., Chauliac, F., & Samama, M. M. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03184.x · Cited by 166
Holmer, E., Mattsson, C., & Nilsson, S. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90089-5 · Cited by 164
Cairns, J. A., Gill, J., Morton, B. C., Roberts, R. E., Gent, M., Hirsh, J., Holder, D. A., Finnie, K., Marquis, J., Naqvi, S. Z., et al. (1996) · Circulation · doi:10.1161/01.cir.94.7.1553 · Cited by 162
Self-citationHeparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome
Warkentin, T. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615864 · Cited by 162
Eichler, P., Budde, U., Haas, S., Kroll, H., Loreth, R. M., Meyer, O., Pachmann, U., Pötzsch, B., Schabel, A., Albrecht, D., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614536 · Cited by 161
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
Shaughnessy, S., Young, E., Deschamps, P., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1368.bloodjournal8641368 · Cited by 152
The Elimination from Plasma of Intravenous Heparin An Experimental Study on Dogs and Humans
Olsson, P., Lagergren, H., & Ek, S. (1963) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1963.tb17446.x · Cited by 147
Bleeding associated with antithrombotic therapy.
Jg, K., & Hirsh, J. (1980) · PubMed · Cited by 147
Self-citationHemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
Fernandez, F., Nguyên, P., van Ryn, J., Ofosu, F. A., Hirsh, J., & Buchanan, M. R. (1986) · Thrombosis Research · doi:10.1016/0049-3848(86)90094-0 · Cited by 139
Self-citationFour Heparin Preparations: Anti-Xa Potentiating Effect of Heparin after Subcutaneous Injection
Johnson, E. A., Kirkwood, T. B. L., Stirling, Y., et al. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648001 · Cited by 137
Heparin kinetics determined by three assay methods
Bjornsson, T. D., Wolfram, K. M., & Kitchell, B. B. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.16 · Cited by 136
Nesheim, M. E. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43920-2 · Cited by 131
An objective study of alternative methods of heparin administration
Bentley, P. G., Kakkar, V. V., Scully, M. F., MacGREGOR, I. R., Webb, P. J., Chan, P. S., & Jones, N. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90182-6 · Cited by 126
Vascular sequestration of heparin
Mahadoo, J., Hiebert, L. M., & Jaques, L. B. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90087-7 · Cited by 126
Heit, J. A., Berkowitz, S. D., Bona, R., Cabanas, V., Corson, J. D., Elliott, C. G., Lyons, R. M., & (Ardeparin Arthroplasty Study Group) (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655902 · Cited by 124
Ofosu, F. A., Siè, P., Modi, G. J., Fernandez, F., Buchanan, M. R., Blajchman, M. A., Boneu, B., & Hirsh, J. (1987) · Biochemical Journal · doi:10.1042/bj2430579 · Cited by 123
Self-citationThe Effectiveness of Implementing the Weight-Based Heparin Nomogram as a Practice Guideline
Raschke, R. A., Gollihare, B., & Peirce, J. C. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440140067006 · Cited by 120
Efficacy and Safety of Enoxaparin to Prevent Deep Venous Thrombosis after Hip Replacement Surgery
Spiro, T. E., Johnson, G. J., Christie, M. J., Lyons, R. M., Macfarlane, D. E., Blasier, R. B., & Tremaine, M. D. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-2-199407150-00001 · Cited by 119
Mitusch, R., Slemens, H. J., Garbe, M., Wagner, T., Sheikhzadeh, A., & DIEDERICH, K. W. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650247 · Cited by 118
Impairment by Heparin of Primary Haemostasis and Platelet [14C]5‐Hydroxytryptamine Release
Heiden, D., Mielke, C. H., & Rodvien, R. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb00666.x · Cited by 117
Factor‐Xa Inactivation by Antithrombin III
Marciniak, E. (1973) · British Journal of Haematology · doi:10.1111/j.1365-2141.1973.tb01662.x · Cited by 116
Heparin therapy: A randomized prospective study
Wilson, J. R., & Lampman, J. H. (1979) · American Heart Journal · doi:10.1016/0002-8703(79)90349-1 · Cited by 116
Hirsh, J., & Weitz, J. I. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09233-2 · Cited by 114
Self-citationCatabolism of low-dose heparin in man
Dawes, J., & Pepper, D. S. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90004-5 · Cited by 113
Hirsh, J. (1998) · Circulation · doi:10.1161/01.cir.98.15.1575 · Cited by 113
Self-citationPrins, M. H., Gelsema, R. G., Sing, A. K., van Heerde, L. R., & den Ottolander, G. J. H. (2009) · Haemostasis · doi:10.1159/000215979 · Cited by 111
Management of Barrett's oesophagus
Kelley, D. J., & Shah, J. P. (1996) · The Lancet · doi:10.1016/s0140-6736(05)64794-0 · Cited by 110
Gent, M., Hirsh, J., Ginsberg, J., Powers, P., Levine, M. N., Geerts, W. H., Jay, R. M., Leclerc, J. E., Neemeh, J. A., & Turpie, A. G. G. (1996) · Circulation · doi:10.1161/01.cir.93.1.80 · Cited by 109
Self-citationHeparin with two binding sites for antithrombin or platelet factor 4.
Jordan, R. E., Favreau, L. V., Braswell, E. H., & ROSENBERG, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68378-x · Cited by 107
Hamulyák, K., Lensing, A. W. A., van der Meer, J., Smid, W. M., van Ooy, A., Hoek, J. A., & for the Fraxiparine Oral Anticoagulant Study Group (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649959 · Cited by 106
Heit, J. A., Berkowitz, S. D., Bona, R., et al. (1997) · PubMed · Cited by 106
Blajchman, M. A., Young, E., & Ofosu, F. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22507.x · Cited by 105
Ofosu, F. A., Hirsh, J., Esmon, C. T., Modi, G. J., Smith, L. M., Anvari, N., Buchanan, M. R., Fenton, J. W., & Blajchman, M. A. (1989) · Biochemical Journal · doi:10.1042/bj2570143 · Cited by 96
Self-citationFrostfeldt, G., Ahlberg, G., Gustafsson, G., Helmius, G., Lindahl, B., Nygren, A., Siegbahn, A., Swahn, E., Venge, P., & Wallentin, L. C. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00612-3 · Cited by 96
Heparin therapy in venous thromboembolism
Wilson, J., BYNUM, L. J., & Parkey, R. W. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90537-4 · Cited by 96
EFFECTIVENESS OF LOW-DOSE HEPARIN IN PREVENTION OF MYOCARDIAL REINFARCTION
Serneri, G. G. N., Gensini, G., Carnovali, M., Rovelli, F., Pirelli, S., & Fortini, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90291-1 · Cited by 93
Characterization of specific receptors for vasopressin in the pituitary gland
Lutz‐Bucher, B., & Koch, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80171-5 · Cited by 91
Lassila, R., Badimón, J. J., Vallabhajosula, S., & Badimón, L. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.306 · Cited by 91
Andersson, G., Fagrell, B., HOLMGREN, K., Johnsson, H., Ljungberg, B., Nilsson, E., Wilhelmsson, S., & ZETTERQUIST, S. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90001-9 · Cited by 88
Recurrent Venous Thrombosis and Heparin Therapy
Anand, S. S., Bates, S., Ginsberg, J. S., Levine, M., Buller, H. R., Prins, M. H., Haley, S., Kearon, C., Hirsh, J., & Gent, M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.17.2029 · Cited by 88
Self-citationCharbonnier, B., Fiessinger, J., Banga, J. D., Wenzel, E., d’Azemar, P., Sagnard, L., & FRAXODI group (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615089 · Cited by 86
Heparin in Acute Stroke With Atrial Fibrillation
Chamorro, Á., Vila, N., Ascaso, C., & Blanc, R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.9.1098 · Cited by 86
Highly active heparin species with multiple binding sites for antithrombin
ROSENBERG, R. D., Jordan, R. E., Favreau, L. V., & Lam, L. H. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)90260-2 · Cited by 85
Faunø, P. Z., Suomalainen, O. T., Rehnberg, V., Hansen, T. B., Krøner, K., Soimakallio, S., & Nielsen, E. (1994) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199412000-00007 · Cited by 84
Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
Kaplan, K. J., Davison, R., Parker, M. A., Mayberry, B., Feiereisel, P., & Salinger, M. H. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90792-2 · Cited by 83
Pini, M., Pattacini, C., Quintavalla, R., Poli, T., Megha, A., Tagliaferri, A., Manotti, C., & Dettori, A. G. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647289 · Cited by 82
Agnelli, G., Pascucci, C., Cosmi, B., & Nenci, G. G. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645195 · Cited by 82
Mahaffey, K. W., Granger, C. B., Collins, R., O’Connor, C. M., Ohman, E. M., Bleich, S. D., Col, J. J., & Califf, R. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89305-8 · Cited by 81
Hanke, H., Oberhoff, M., Hanke, S., Hassenstein, S., Kamenz, J., Schmid, K. M., BETZ, E., & Karsch, K. R. (1992) · Circulation · doi:10.1161/01.cir.85.4.1548 · Cited by 76
HEPARIN DOSES AND MAJOR BLEEDINGS
Morabia, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91421-2 · Cited by 74
Roijer, A., Eskilsson, J., & Olsson, B. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1869 · Cited by 68
Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin
Eika, C. (1971) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1971.tb01976.x · Cited by 67
GRIFFITH, M. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5460 · Cited by 65
Buchwald, A. B., Unterberg‐Buchwald, C., Nebendahl, K., Gröne, H., & Wiegand, V. (1992) · Circulation · doi:10.1161/01.cir.86.2.531 · Cited by 65
Cited by
RNA aptamers as reversible antagonists of coagulation factor IXa
Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512
The anti-inflammatory effects of heparin and related compounds
Young, E. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.026 · Cited by 390
Goldhaber, S. Z. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16004-2 · Cited by 348
Microemulsions as carriers for drugs and nutraceuticals
Spernath, A., & Aserin, A. (2006) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2006.11.016 · Cited by 325
Begovac, P. C., Thomson, R. C., Fisher, J. L., Hughson, A., & Gällhagen, A. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1909 · Cited by 198
Metadata
- Authors
- Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V.
- Venue
- Circulation
- Published
- 2001-06-19
- Volume
- 103
- Issue
- 24
- Pages
- 2994-3018
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2171713512
- Cited by
- 565
- References
- 209
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.